Atlas Trials

Celecoxib Through Surgery and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer

Clinical trial NCT04162873 · TERMINATED

Trial details

NCT number
NCT04162873
Sponsor
University of Utah
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Nasal Cavity and Paranasal Sinus CarcinomaOral Cavity CarcinomaPathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Pathologic Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Recurrent Hypopharyngeal CarcinomaRecurrent Laryngeal CarcinomaRecurrent Nasal Cavity and Paranasal Sinus CarcinomaRecurrent Oral Cavity CarcinomaRecurrent Oropharyngeal CarcinomaStage III Hypopharyngeal Carcinoma AJCC v8
Start date
2019-11-27
Primary completion
2023-02-28
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.